ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies

Xu, Yidan; Zhu, Huiqiu; Li, Weiwei; Chen, Danxia; Xu, Ying; Xu, Aimin*; Ye, Dewei*广东药学院
Pharmacology and Therapeutics2022-12DOI: 10.1016/j.pharmthera.2022.108284
8被引12阅读
引用收藏
分享

摘要

Polycystic ovary syndrome (PCOS) affects approximately 15% of women of reproductive age worldwide. It is the most prevalent endocrine disorder with marked risks for female infertility, type 2 diabetes mellitus (T2DM), psy-chiatric disorders and gynecological cancers. Although the pathophysiology of PCOS remains largely elusive, growing evidence suggests a close link with obesity and its related metabolic disorders. As a highly active endo-crine cell population, hypertrophic adipocytes in obesity have disturbed production of a vast array of adipokines, biologically active peptides that exert pleiotropic effects on homeostatic regulation of glucose and lipid metabo-lism. In parallel with their crucial roles in the pathophysiology of obesity-induced metabolic diseases, adipokines have recently been identified as promising targets for novel therapeutic strategies for multiple diseases. Current treatments for PCOS are suboptimal with insufficient alleviation of all symptoms. Novel findings in adipokine-targeted agents may provide important insight into the development of new drugs for PCOS. This Review pre-sents an overview of the current understanding of mechanisms that link PCOS to obesity and highlights emerging evidence of adipose-ovary crosstalk as a pivotal mediator of PCOS pathogenesis. We summarize recent findings of preclinical and clinical studies that reveal the therapeutic potential of adipokine-targeted novel approaches to PCOS and its related metabolic disorders. We also discuss the critical gaps in knowledge that need to be addressed to guide the development of adipokine-based novel therapies for PCOS.

学科与关键词

关键词
Adipose tissueFatMetabolic hormonesHyperandrogenismInsulin resistance
相关
加载中…
  • The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome
    Aydogan, Aydogdu; Gokhan, Uckaya; Ilker, Tasci; Oben, Baysan; Serkan, Tapan; Baris, Bugan; Muhittin, Serdar; Halil, Akbulut; Umit, Aydogan; Alper, Sonmez; Sebnem, Aydogdu; Mustafa, KutluEndocrine Journal, 2012, 59(6): 509-516.被引 9
  • The role of androgen and its related signals in PCOS
    Ye, Wenting; Xie, Tingting; Song, Yali*; Zhou, Lili*Journal of Cellular and Molecular Medicine, 2021, 25(4): 1825-1837.被引 55
  • Depression in polycystic ovary syndrome: Focusing on pathogenesis and treatment
    Xing, Liwei; Xu, Jinlong; Wei, Yuanyuan; Chen, Yang; Zhuang, Haina; Tang, Wei; Yu, Shun; Zhang, Junbao; Yin, Guochen; Wang, Ruirui*; Zhao, Rong*; Qin, Dongdong*Frontiers in Psychiatry, 2022, 13: 1001484.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmacology and Therapeutics
发表日期
2022-12
卷期
第 240 卷
页码
108284
DOI
10.1016/j.pharmthera.2022.108284
语言
ENGLISH
成果收录
SCIE
资助标注
NSFC [81922074, 81770849, 81703906]; Key Laboratory of Model Animal Phenotyping and Basic Research in Metabolic Diseases [2018KSYS003]

作者

  • X

    Xu, Yidan (第一作者)

    guangdong pharmaceut univ

  • Z

    Zhu, Huiqiu

    guangdong pharmaceut univ

查看全部 7 位作者收起作者
  • L

    Li, Weiwei

    guangdong pharmaceut univ

  • C

    Chen, Danxia

    guangdong pharmaceut univ

  • X

    Xu, Ying

    guangdong pharmaceut univ

  • X

    Xu, Aimin (通讯)

    univ hong kong

  • Y

    Ye, Dewei (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417